Care Markets

MITIE’s homecare division continues to perform above the sector average in terms of operating margins, according to its half-yearly results. However, the projected revenues of...

A new integrated dementia service, run by a consortium of 162 GPs across 41 practices in Staffordshire, has landed the top award in the...

Property consultant Knight Frank has predicted that care home provider HC-One will be sold by the end of the year, adding further fuel to...

Independent mental healthcare providers should have been inspected under the new Care Quality Commission (CQC) regime by October 2015, according to chief inspector of...

Specialist care provider Tracscare could be up for sale in the near future, according to industry speculation.

The Abbeyfield Kent Society has opened a new dementia wing at its Greensted care home in Wateringbury, Maidstone. It extends existing facilities at the home...

Following two major acquisitions, Voyage reported revenues of £181.4m for the year ended 31 March 2013, an increase of 27.5% on the previous year’s...

Legal experts Tim Nye and Kyle Holling discuss their work across the social care arena and the wider issues impacting providersCan you both tell...

Ecclesiastical Insurance Office, the largest provider of insurance in the UK care home sector, this week announced that it will withdraw from the care...

CareTech enjoyed a solid trading period for the year ending 30 September 2013, its preliminary, unaudited results show. Turnover remained steady at £114.3m (2012: £114.1m) and underlying EBITDA was boosted to £26.4m (2012: £24.9m) as a result of a small reduction in underlying cost of sales and a larger reduction in underlying administrative expenses. At 23.6% of revenue, CareTech’s underlying EBITDA puts it in the middle rank of profitability among learning disability care home groups. Total EBITDA declared by the company was even rosier, leaping to £39.9m (2012: £21.3m) as a result on some chunky non-underlying’ items. The biggest of these was an £18.5m gain recognised in respect of business combinations’. Netted against a number of non-underlying acquisition expenses totalling £5m this added £13.5m into the total 2013 EBITDA pot (2012: £-3.5m, in the absence of any similar revaluation gains).